Tom Lemberg

Tom Lemberg is a visionary entrepreneur and founder in the healthcare technology space, best known for establishing Curebase to revolutionize clinical trials. His mission is to make clinical research accessible to any patient, anywhere, focusing on decentralization and patient-centric approaches. Under his leadership, Curebase secured over $58M in funding, served hundreds of thousands of patients, and was recognized on Forbes 30 Under 30. He is an alumnus of Y Combinator (S18) and has been instrumental in modernizing clinical trial processes, particularly during the COVID-19 pandemic. forbes+3

With a strong academic background in Computer Science and Molecular and Cellular Biology from Harvard University, Tom Lemberg possesses a unique interdisciplinary perspective. He has consistently applied his technical expertise to solve complex problems in medicine and health throughout his career. His early experiences include research on depression biomarkers at the Wyss Institute and software development roles at Amazon and athenahealth, demonstrating a consistent dedication to merging technology with life sciences. moneyinc+1

Before founding Curebase, Tom Lemberg gained valuable experience in product management at Syapse, where he focused on EMR integration, tumor board decision support, and clinical trial matching engines. This hands-on experience in oncology software and real-world evidence solutions laid a crucial foundation for his subsequent entrepreneurial endeavors, enabling him to deeply understand the inefficiencies within the clinical trial landscape that he later sought to address with Curebase. moneyinc+1